Skip to main content Skip to main menu
UF Health University of Florida
College of Pharmacy UNIVERSITY of FLORIDA
Apply to Pharm.D. Program
Kathryn E DeSear

Kathryn E DeSear, Pharm.D.

Clinical Associate Professor

Department: Pharmacy Education and Practice
Business Phone: (352) 273-6236
Business Email: katysa33@ufl.edu
CV: View Curriculum Vitae

On This Page

About Kathryn E DeSear

Kate DeSear, Pharm.D., BCIDP, FIDSA, is an associate professor in the Department of Pharmacy Education and Practice in the University of Florida College of Pharmacy. She maintains a practice site as a clinical specialist in infectious diseases at UF Health Shands Hospital, an 1,162 bed academic medical center, and co-leads the antimicrobial stewardship program. She serves as the residency program director of the Infectious Diseases PGY-2 residency.

DeSear received her Doctor of Pharmacy degree from the University of Florida. She completed her pharmacy practice residency at Bay Pines Veterans Affairs Hospital and a specialty residency in infectious diseases at the UF Health Shands Hospital. Her areas of interest include antimicrobial stewardship, novel stewardship measures relating antimicrobial use to clinical and process outcomes, and gram negative resistance.

She is an active member of IDSA, serving previously on the Recognitions and Awards Committee; and an active member of the Society of Infectious Diseases Pharmacists, serving in many leadership roles including past treasurer of the society.

Teaching Profile

Courses Taught

  1. PHA5782C – Patient Care 2: Introduction to Infectious Disease and Oncology

    College of Pharmacy

  2. PHA5788C – Patient Care 6

    College of Pharmacy

Board Certifications

  • Board Certified Infectious Diseases Pharmacist
    BPS

Clinical Profile

Areas of Interest

  • Infectious Diseases

Publications

Academic Articles

Grants

  1. Ceftazidime-Avibactam versus Meropenem-Vaborbactam for the treatment of bloodstream infections and/or pneumonia due to carbapenem-resistant EnterobacteraLes

    Active

    Role:
    Co-Investigator
    Funding:
    UNIV OF PITTSBURGH via Melinta Therapeutics

  2. Optimizing escalation: Ceftolozane/tazobactam versus treatment with traditional anti-pseudomonal ?-lactams for pneumonia or bloodstream infections due to MDR P. aeruginosa (STEWARDS)

    Active

    Role:
    Co-Investigator
    Funding:
    UNIV OF PITTSBURGH via MERCK SHARP & DOHME

  3. Cefiderocol treatment Versus ceftolozane/tazobactam for the treatment of pneumonia and/or bloodstream Infections due to multidrug-resistant Pseudomonas aeruginosa (CONVINCE)

    Active

    Role:
    Principal Investigator
    Funding:
    UNIV OF PITTSBURGH via SHIONOGI INC

  4. Prevalence of Cefazolin Inoculum Effect in Mcthicillin Susceptible Staphylococcus aureus Bacteremia

    Role:
    Co-Investigator
    Funding:
    UF HEALTH SHANDS HOSPITAL

Education

  1. PharmD

    University of Florida

Contact Details

Phones:
Business:
(352) 273-6236
Emails:
Business:
katysa33@ufl.edu
Addresses:
Business Mailing:
PO Box 100486
 GAINESVILLE FL 32610
Business Street:
1225 CENTER DR
 GAINESVILLE FL 32610